Cargando…

Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch

Expanded polyglutamine (polyQ) stretches in at least nine unrelated proteins lead to inherited neuronal dysfunction and degeneration. The expansion size in all diseases correlates with age at onset (AO) of disease and with polyQ protein aggregation, indicating that the expanded polyQ stretch is the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuiper, E. F. E., de Mattos, Eduardo P., Jardim, Laura B., Kampinga, Harm H., Bergink, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362620/ https://www.ncbi.nlm.nih.gov/pubmed/28386214 http://dx.doi.org/10.3389/fnins.2017.00145

Ejemplares similares

FOXO1 controls protein synthesis and transcript abundance of mutant polyglutamine proteins, preventing protein aggregation
por: Furtado, Gabriel Vasata, et al.
Publicado: (2021)

DNAJB6 is a peptide-binding chaperone which can suppress amyloid fibrillation of polyglutamine peptides at substoichiometric molar ratios
por: Månsson, Cecilia, et al.
Publicado: (2013)

DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease
por: Joshi, Bhagyashree S., et al.
Publicado: (2021)

Co-chaperones DNAJA1 and DNAJB6 are critical for regulation of polyglutamine aggregation
por: Rodríguez-González, Claudio, et al.
Publicado: (2020)

Cytoplasmic Localization and the Choice of Ligand Determine Aggregate Formation by Androgen Receptor with Amplified Polyglutamine Stretch
por: Becker, Matthias, et al.
Publicado: (2000)

Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases
por: Minakawa, Eiko N., et al.
Publicado: (2021)

DNAJs: more than substrate delivery to HSPA
por: Dekker, Suzanne L., et al.
Publicado: (2015)

Protein Quality Control Pathways at the Crossroad of Synucleinopathies
por: De Mattos, Eduardo P., et al.
Publicado: (2020)

Candida albicans Is Resistant to Polyglutamine Aggregation and Toxicity
por: Leach, Michelle D., et al.
Publicado: (2016)

Targeting DNA topoisomerases or checkpoint kinases results in an overload of chaperone systems, triggering aggregation of a metastable subproteome
por: Huiting, Wouter, et al.
Publicado: (2022)

Deletion of the Huntingtin Polyglutamine Stretch Enhances Neuronal Autophagy and Longevity in Mice
por: Zheng, Shuqiu, et al.
Publicado: (2010)

Versatile members of the DNAJ family show Hsp70 dependent anti-aggregation activity on RING1 mutant parkin C289G
por: Kakkar, Vaishali, et al.
Publicado: (2016)

Misfolding of Proteins with a Polyglutamine Expansion Is Facilitated by Proteasomal Chaperones
por: Rousseau, Erwann, et al.
Publicado: (2009)

An Engineered Viral Protease Exhibiting Substrate Specificity for a Polyglutamine Stretch Prevents Polyglutamine-Induced Neuronal Cell Death
por: Sellamuthu, Saravanan, et al.
Publicado: (2011)

Molecular Origin of Polyglutamine Aggregation in Neurodegenerative Diseases
por: Khare, Sagar D, et al.
Publicado: (2005)

Formation and persistence of polyglutamine aggregates in mistranslating cells
por: Lant, Jeremy T, et al.
Publicado: (2021)

Identities of Sequestered Proteins in Aggregates from Cells with Induced Polyglutamine Expression
por: Suhr, Steven T., et al.
Publicado: (2001)

The 11S Proteasomal Activator REGγ Impacts Polyglutamine-Expanded Androgen Receptor Aggregation and Motor Neuron Viability through Distinct Mechanisms
por: Yersak, Jill M., et al.
Publicado: (2017)

The Emerging Role of microRNAs in Polyglutamine Diseases
por: Dong, Xiaoyu, et al.
Publicado: (2019)

The Mechanisms of Nuclear Proteotoxicity in Polyglutamine Spinocerebellar Ataxias
por: Lee, Davin, et al.
Publicado: (2020)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Possible Function of Molecular Chaperones in Diseases Caused by Propagating Amyloid Aggregates
por: Lazarev, Vladimir F., et al.
Publicado: (2017)

Examination of Ataxin-3 (atx-3) Aggregation by Structural Mass Spectrometry Techniques: A Rationale for Expedited Aggregation upon Polyglutamine (polyQ) Expansion
por: Scarff, Charlotte A., et al.
Publicado: (2015)

Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation
por: Howard, Rebecca A, et al.
Publicado: (2007)

Recruitment and the Role of Nuclear Localization in Polyglutamine-mediated Aggregation
por: Perez, Matthew K., et al.
Publicado: (1998)

Cell-to-cell Transmission of Polyglutamine Aggregates in C. elegans
por: Kim, Dong-Kyu, et al.
Publicado: (2017)

Molecular dynamics analysis of the aggregation propensity of polyglutamine segments
por: Wen, Jingran, et al.
Publicado: (2017)

The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation
por: Knier, Adam S., et al.
Publicado: (2022)

The Ubiquitination, Disaggregation and Proteasomal Degradation Machineries in Polyglutamine Disease
por: Nath, Samir R., et al.
Publicado: (2017)

A homogeneous dataset of polyglutamine and glutamine rich aggregating peptides simulations
por: Barrera, Exequiel E., et al.
Publicado: (2021)

Cytoplasmic Ubiquitin-Specific Protease 19 (USP19) Modulates Aggregation of Polyglutamine-Expanded Ataxin-3 and Huntingtin through the HSP90 Chaperone
por: He, Wen-Tian, et al.
Publicado: (2016)

PolyQ Database—an integrated database on polyglutamine diseases
por: Estevam, Bernardo, et al.
Publicado: (2023)

Chaperone Mediated Autophagy Degrades TDP-43 Protein and Is Affected by TDP-43 Aggregation
por: Ormeño, Fernando, et al.
Publicado: (2020)

Nuclear polyglutamine-containing protein aggregates as active proteolytic centers
por: Chen, Min, et al.
Publicado: (2008)

Prion Formation and Polyglutamine Aggregation Are Controlled by Two Classes of Genes
por: Manogaran, Anita L., et al.
Publicado: (2011)

Proteins with Intrinsically Disordered Domains Are Preferentially Recruited to Polyglutamine Aggregates
por: Wear, Maggie P., et al.
Publicado: (2015)

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
por: Takeuchi, Toshihide, et al.
Publicado: (2017)

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion
por: Niewiadomska-Cimicka, Anna, et al.
Publicado: (2020)

Editorial: The role of posttranslational modifications in polyglutamine diseases
por: Weber, Jonasz Jeremiasz, et al.
Publicado: (2023)

Modifiers of mutant huntingtin aggregation: functional conservation of C. elegans-modifiers of polyglutamine aggregation
por: Teuling, Eva, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0nu3e6p8bc5ecn5dpe08kablq7